🚀 VC round data is live in beta, check it out!
DocMorris Valuation Multiples
Discover revenue and EBITDA valuation multiples for DocMorris and similar public comparables like Cawachi, Wish, JZJ Chain Drugstore, Aramis Group and more.
DocMorris Overview
About DocMorris
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
Founded
1993
HQ
Employees
1.5K
Website
Financials (LTM)
EV
$513M
DocMorris Financials
DocMorris reported last 12-month revenue of $1B and negative EBITDA of ($53M).
In the same LTM period, DocMorris generated $317M in gross profit, ($53M) in EBITDA losses, and had net loss of ($151M).
Revenue (LTM)
DocMorris P&L
In the most recent fiscal year, DocMorris reported revenue of $1B and EBITDA of ($48M).
DocMorris expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $317M | XXX | $276M | XXX | XXX | XXX |
| Gross Margin | 22% | XXX | 21% | XXX | XXX | XXX |
| EBITDA | ($53M) | XXX | ($48M) | XXX | XXX | XXX |
| EBITDA Margin | (4%) | XXX | (4%) | XXX | XXX | XXX |
| EBIT Margin | (8%) | XXX | (10%) | XXX | XXX | XXX |
| Net Profit | ($151M) | XXX | ($124M) | XXX | XXX | XXX |
| Net Margin | (10%) | XXX | (10%) | XXX | XXX | XXX |
| Net Debt | — | — | $243M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
DocMorris Stock Performance
DocMorris has current market cap of $410M, and enterprise value of $513M.
Market Cap Evolution
DocMorris' stock price is $8.44.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $513M | $410M | 3.8% | XXX | XXX | XXX | $-2.56 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDocMorris Valuation Multiples
DocMorris trades at 0.4x EV/Revenue multiple, and (9.7x) EV/EBITDA.
EV / Revenue (LTM)
DocMorris Financial Valuation Multiples
As of April 18, 2026, DocMorris has market cap of $410M and EV of $513M.
Equity research analysts estimate DocMorris' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DocMorris has a P/E ratio of (2.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $410M | XXX | $410M | XXX | XXX | XXX |
| EV (current) | $513M | XXX | $513M | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | (9.7x) | XXX | (10.7x) | XXX | XXX | XXX |
| EV/EBIT | (4.6x) | XXX | (3.9x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.6x | XXX | 1.9x | XXX | XXX | XXX |
| P/E | (2.7x) | XXX | (3.3x) | XXX | XXX | XXX |
| EV/FCF | (3.7x) | XXX | (7.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DocMorris Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
DocMorris Margins & Growth Rates
DocMorris' revenue in the last 12 month grew by 10%.
DocMorris' revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.3M for the same period.
DocMorris' rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DocMorris' rule of X is 22% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
DocMorris Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | (4%) | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Growth | (66%) | XXX | 31% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 8% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | 13% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
DocMorris Public Comps
See public comps and valuation multiples for other Consumer E-commerce and Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| DocMorris | XXX | XXX | XXX | XXX | XXX | XXX |
| Cawachi | XXX | XXX | XXX | XXX | XXX | XXX |
| Wish | XXX | XXX | XXX | XXX | XXX | XXX |
| JZJ Chain Drugstore | XXX | XXX | XXX | XXX | XXX | XXX |
| Aramis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Nice One | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DocMorris M&A Activity
DocMorris acquired XXX companies to date.
Last acquisition by DocMorris was on XXXXXXXX, XXXXX. DocMorris acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by DocMorris
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDocMorris Investment Activity
DocMorris invested in XXX companies to date.
DocMorris made its latest investment on XXXXXXXX, XXXXX. DocMorris invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by DocMorris
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DocMorris
| When was DocMorris founded? | DocMorris was founded in 1993. |
| Where is DocMorris headquartered? | DocMorris is headquartered in Switzerland. |
| How many employees does DocMorris have? | As of today, DocMorris has over 1K employees. |
| Is DocMorris publicly listed? | Yes, DocMorris is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of DocMorris? | DocMorris trades under DOCM ticker. |
| When did DocMorris go public? | DocMorris went public in 2017. |
| Who are competitors of DocMorris? | DocMorris main competitors are Cawachi, Wish, JZJ Chain Drugstore, Aramis Group. |
| What is the current market cap of DocMorris? | DocMorris' current market cap is $410M. |
| What is the current revenue of DocMorris? | DocMorris' last 12 months revenue is $1B. |
| What is the current revenue growth of DocMorris? | DocMorris revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of DocMorris? | Current revenue multiple of DocMorris is 0.4x. |
| Is DocMorris profitable? | No, DocMorris is not profitable. |
| What is the current EBITDA of DocMorris? | DocMorris has negative EBITDA and is not profitable. |
| What is DocMorris' EBITDA margin? | DocMorris' last 12 months EBITDA margin is (4%). |
| What is the current EV/EBITDA multiple of DocMorris? | Current EBITDA multiple of DocMorris is (9.7x). |
| What is the current FCF of DocMorris? | DocMorris' last 12 months FCF is ($137M). |
| What is DocMorris' FCF margin? | DocMorris' last 12 months FCF margin is (9%). |
| What is the current EV/FCF multiple of DocMorris? | Current FCF multiple of DocMorris is (3.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.